Literature DB >> 2416192

Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.

H von Holst, C Lindquist, G Sedvall.   

Abstract

The concentrations of the dopamine metabolite homovanillic acid (HVA), the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) and the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MOPEG) were determined in cerebrospinal fluid (CSF) from patients with subarachnoid haemorrhage (SAH) using a mass fragmentographic method. In a first group of 24 patients lumbar CSF was collected during the first 10 days after SAH. The concentrations of HVA and 5-HIAA showed a several-fold increase in the majority of subjects while that for MOPEG was less pronounced in comparison to controls. In a second group of 12 SAH-patients, CSF was collected in 10 ml fractions during surgical clipping of aneurysms. The mean concentrations of HVA, 5-HIAA and MOPEG in lumbar CSF was 469,275 and 39 pmol/l, respectively, whereas central CSF concentrations were 1,212, 499 and 48 pmol/ml, respectively. Compared to healthy controls, both HVA and 5-HIAA showed increased levels (pl 0,01) but MOPEG was within the normal range. No correlation between the concentrations of the monoamine metabolites, the neurological condition or the cerebral vascular diameter was observed in neither of the two groups. It is suggested that the accumulation of HVA and 5-HIAA in SAH patients is explained by a disturbance of the active transport mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416192     DOI: 10.1007/bf01476218

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  18 in total

1.  Disordered neurotransmitter function. Demonstration by measurement of norepinephrine and 5-hydroxytryptamine in CSF of patients with recent cerebral infarction.

Authors:  J S Meyer; K M Welch; S Okamoto; K Shimazu
Journal:  Brain       Date:  1974-12       Impact factor: 13.501

2.  Proceedings: amine levels in the cerebrospinal fluid after subarachnoid haemorrhage.

Authors:  B H Cummins; D Lothian; J H Peacock
Journal:  Br J Surg       Date:  1973-11       Impact factor: 6.939

3.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

4.  Normal size of the internal carotid, middle cerebral and anterior cerebral arteries.

Authors:  T O Gabrielsen; T Greitz
Journal:  Acta Radiol Diagn (Stockh)       Date:  1970-01

5.  Brain edema factors: current state with particular reference to plasma constituents and glutamate.

Authors:  A Baethmann; W Oettinger; W Rothenfusser; O Kempski; A Unterberg; R Geiger
Journal:  Adv Neurol       Date:  1980

6.  Changes of some putative neurotransmitters in human cerebral infarction.

Authors:  K Jellinger; P Riederer; P Kothbauer
Journal:  J Neural Transm Suppl       Date:  1978

7.  Concentration gradients of monoamine metabolites in human cerebrospinal fluid.

Authors:  R Sjöström; J Ekstedt; E Anggård
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

8.  Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.

Authors:  B Sandgárde; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

9.  Cerebral blood flow, cerebrovascular resistance, cerebral metabolic rate of oxygen and intracranial pressure during and after severe prolonged arterial hypoxia in dogs. The role of dopamine in the deep hypoxic state.

Authors:  B Ekström-Jodal; J Elfverson; C von Essen
Journal:  Acta Neurol Scand       Date:  1979-07       Impact factor: 3.209

10.  Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.

Authors:  L Hagenfeldt; L Bjerkenstedt; G Edman; G Sedvall; F A Wiesel
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

View more
  3 in total

1.  Alterations of monoamine metabolites and of tryptophan in the basal cisternal CSF of patients after subarachnoid haemorrhage.

Authors:  Y Suzuki; K Ogura; M Shibuya; T Okada; N Kageyama; I Yamamoto; M Hara
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

2.  Positron emission tomography with 68-Ga-EDTA and computed tomography in patients with subarachnoid haemorrhage.

Authors:  H von Holst; K Ericson; G Edner
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  The amount of blood in CSF and degree of hydrocephalus studied with CT as compared to clinical condition and concentrations of various substances in human CSF after subarachnoid haemorrhage.

Authors:  H von Holst; G Bergstrand
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.